• 4CMenB journey to the 10-year anniversary and beyond
• A DAMP-Based Assay for Rapid and Affordable Diagnosis of Bacterial Meningitis Agents: Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae
• A Fluorinated Sialic Acid Vaccine Lead Against Meningitis B and C
• A novel biosensing strategy for identification of three important bacteria causing meningitis
• A phase 3 non-inferiority trial of locally manufactured Meningococcal ACWY vaccine 'Ingovax ACWY' among Bangladeshi adults
• A rare case report of meningoencephalitis caused by Streptococcus porcinus
• A Rare Cause of Preseptal Cellulitis: Neisseria meningitidis
• Addressing the risk of global spread of Neisseria meningitidis: strategies for the forthcoming 2024 Hajj following cases in the UK, France, and the USA
• Aetiological profile of acute encephalitis syndrome in Assam, India, during a 4-year period from 2019 to 2022
• An Assessment of a New Rapid Multiplex PCR Assay for the Diagnosis of Meningoencephalitis
• An Automated Versatile Diagnostic Workflow for Infectious Disease Detection in Low-Resource Settings
• An integrated in silico approach for the identification of novel potential drug target and chimeric vaccine against Neisseria meningitides strain 331401 serogroup X by subtractive genomics and reverse vaccinology
• An isothermal CRISPR- based lateral flow assay for detection of Neisseria meningitidis
• An Outbreak of Serogroup Y Meningococcal Meningitis in a Private Secondary Vocational School - Guangzhou City, Guangdong Province, China, 2023
• Analyzing the dynamics of meningococcal vaccinations initiatives by local government units in Poland (2017-2021) - Scope, challenges and recommendations
• Angiopoietin-like 4 protects against endothelial dysfunction during bacterial sepsis
• Antigenic determinants driving serogroup-specific antibody response to Neisseria meningitidis C, W, and Y capsular polysaccharides: Insights for rational vaccine design
• Automating the Generation of Notifiable Bacterial Disease Reports: Proof-of-Concept Study and Implementation in Six Hospitals in Thailand
• Available evidence on the co-administration of the four-component meningococcal B vaccine (4CMenB) with three vaccines at the same visit among pediatric individuals
• Bacterial discrimination by Fourier transform infrared spectroscopy, MALDI-mass spectrometry and whole-genome sequencing
• Bactericidal Antibody Responses to Meningococcal Recombinant Outer Membrane Proteins
• Bactericidal human monoclonal antibody 1B1 shows specificity for meningococcal factor H binding protein variant 2 and displaces human factor H
• Carriage of Neisseria meningitidis (meningococci) in the sputum of people with cystic fibrosis (CF): occupational health risks and mitigating interventions for physiotherapists
• Cases of Meningococcal Disease Associated with Travel to Saudi Arabia for Umrah Pilgrimage - United States, United Kingdom, and France, 2024
• Children with perinatally acquired HIV exhibit distinct immune responses to 4CMenB vaccine
• Comprehensive observational study evaluating the enduring effectiveness of 4CMenB, the meningococcal B vaccine against gonococcal infections in the Northern Territory and South Australia, Australia: study protocol
• Concurrent Outbreaks of Hepatitis A, Invasive Meningococcal Disease, and Mpox, Florida, USA, 2021-2022
• Correction: Asymptomatic carriage of Neisseria meningitidis, Haemophilus influenzae, Streptococcus pneumoniae, Group A Streptococcus and Staphylococcus aureus among adults aged 65 years and older
• Developing a Novel Murine Meningococcal Meningitis Model Using a Capsule-Null Bacterial Strain
• Development and validation of multiplex assays for mouse and human IgG and IgA to Neisseria gonorrhoeae antigens
• Dual template (epitope) imprinted electrode for sensing bacterial protein with high selectivity
• Effectiveness and duration of protection of primary and booster immunisation against meningococcal serogroup C disease with meningococcal conjugate C and ACWY vaccines: Systematic review
• Effectiveness of MenB-4C vaccine against gonorrhea: a systematic review and meta-analysis
• Emergence of invasive meningococcal disease during Hajj pilgrimage - vigilance and preparedness, in the post-pandemic year
• Emerging Meningococcal B Meningitis in Japan: A Case Report of a 50-Year-Old Japanese Man with Diabetes
• Enhanced Timeliness and Co-Administration of Meningitis B Vaccination in Children: Impact of Funding in Valencian Community, Spain
• Epidemiological and bacterial profile of childhood meningitis in Tunisia
• Epidemiology and Clinical Outcomes of Bacterial Meningitis in Children and Adults in Low- and Middle-Income Countries
• Estimating the potential number of cases prevented by infant/ toddler immunisation with a MenACWY vaccine
• Etiology, Clinical Presentation, and Outcomes of Bacterial Meningitis in Adult Patients: A Retrospective Study in Lithuania (2018-2021)
• Evaluation of antibody responses in healthcare workers before & after meningococcal vaccine and determination of meningococcal carriage rates
• Evaluation of candidate International Standards for meningococcal capsular polysaccharide groups W and Y
• Evaluation of the Bio-Speedy Meningitis/Encephalitis Panel in the Diagnosis of Central Nervous System Infections
• Expanding the genetic toolbox for Neisseria meningitidis with efficient tools for unmarked gene editing, complementation, and labeling
• Extensive Genetic Diversity and Epidemiological Patterns of Factor H-Binding Protein Variants among Neisseria meningitidis in China
• False negative result in both multiplex and monoplex PCR in a case of Neisseria meningitidis bacteremia. Diagnostic, therapeutic and epidemiological implications
• From cytokines to chemokines: Understanding inflammatory signaling in bacterial meningitis
• Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014
• Genomic diversity and antimicrobial susceptibility of invasive Neisseria meningitidis in South Africa, 2016-2021
• Genomic Surveillance of Invasive Meningococcal Disease During a National MenW Outbreak in Australia, 2017-2018
• Global Case Fatality of Bacterial Meningitis During an 80-Year Period: A Systematic Review and Meta-Analysis
• Highly efficient biosynthesis of 3'-sialyllactose in engineered Escherichia coli
• Hybrid response to SARS-CoV-2 and Neisseria meningitidis C after an OMV-adjuvanted immunization in mice and their offspring
• Identification of active main metabolites of anti-infective inhibitors of the macrophage infectivity potentiator protein by liquid chromatography using mass detection
• Immune interface interference vaccines: An evolution-informed approach to anti-bacterial vaccine design
• Immunogenicity and Protective Capacity of CpG ODN Adjuvanted Alum Adsorbed Bivalent Meningococcal Outer Membrane Vesicle Vaccine
• Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study
• Impact of Protein Nanoparticle Shape on the Immunogenicity of Antimicrobial Glycoconjugate Vaccines
• Interaction of Neisseria meningitidis carrier and disease isolates of MenB cc32 and MenW cc22 with epithelial cells of the nasopharyngeal barrier
• Investigating the importance of selected surface-exposed loops in HpuB for hemoglobin binding and utilization by Neisseria gonorrhoeae
• Investigation and response to an outbreak of Neisseria meningitidis serogroup Y ST-1466 urogenital infections, Australia
• Investigation of a bacterial meningitis cluster in a refugee settlement, Obongi District, Uganda, March 2023
• Kinetic characterization of two neuraminic acid synthases and evaluation of their application potential
• Management of a Neisseria meningitidis case: factors that guarantee the effectiveness of supporting Public Health actions
• Meningococcal meningitis in Chile between 1990 and 2019
• Meningococcal meningitis in Spain in the Horizon 2030: A position paper
• Meningococcal Surveillance Australia: Reporting period 1 April to 30 June 2023
• Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2023
• Meningococcal Surveillance Australia: Reporting period 1 October to 31 December 2023
• Multicentre double-blind randomised placebo-controlled trial evaluating the efficacy of the meningococcal B vaccine, 4CMenB (Bexsero), against Neisseria gonorrhoeae infection in men who have sex with men: the GoGoVax study protocol
• Neisseria meningitidis with decreased susceptibility to penicillin G and molecular characterization of the penA gene in strains isolated at University Hospital Centers of Casablanca and Marrakech (Morocco)
• Neisserial adhesin A (NadA) binds human Siglec-5 and Siglec-14 with high affinity and promotes bacterial adhesion/invasion
• News Brief: Invasive meningococcal disease is on the rise in the United States
• Nurses' preferences regarding MenACWY conjugate vaccines attributes: a discrete choice experiment in Spain
• Occurrence and Distribution of Potential Dangerous Biological Agents in Beijing Suburban Rivers
• Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology
• PCR-positive meningococcal CSF infection without pleocytosis but high IL-6 and IL-8
• Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020
• Prevalence and persistence of Neisseria meningitidis carriage in Swedish university students - CORRIGENDUM
• Prevention and treatment of infection in patients with an absent or hypofunctional spleen: A British Society for Haematology guideline
• Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population
• Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France
• Public health management of invasive meningococcal disease outbreaks: worldwide 1973-2018, a systematic review
• Real-world safety profile of eculizumab: an analysis of FDA adverse event reporting system and systematic review of case reports
• Recent increase in atypical presentations of invasive meningococcal disease in France
• Self-Reported Executive Functioning in Young Adult Survivors of Childhood Bacterial Meningitis
• Serogroup B Invasive Meningococcal Disease in Older Adults Identified by Genomic Surveillance, England, 2022-2023
• Sweet complexity: O-linked protein glycosylation in pathogenic Neisseria
• The Bacterial Meningitis Epidemic in Banalia in the Democratic Republic of Congo in 2021
• The Evaluation of the BioFire FilmArray Meningitis/Encephalitis Panel for the Detection of Bacteria and Yeast in Cerebrospinal Fluid Specimens
• The First Reported Case of Co-Infection with Neisseria Meningitidisand Bordetella Pertussis in the Cerebrospinal Fluid Specimen of a Normal Four-Year-Old Child
• The important lessons lurking in the history of meningococcal epidemiology
• THE ROLE OF SCHOOLS IN MENINGOCOCCAL CARRIAGE AMONG ADOLESCENTS AND YOUNG ADULTS IN SOUTH AUSTRALIA
• Thrombosis and meningococcal infection rates in pegcetacoplan-treated patients with paroxysmal nocturnal hemoglobinuria in the clinical trial and postmarketing settings
• Tonsillectomies are associated with an increased risk of meningococcal carriage
• Urgent Need to Understand and Prevent Gonococcal Infection: From the Laboratory to Real-World Context
• Urogenital infection by Neisseria meningitidis
• Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023
• Vaccine-induced strain replacement: theory and real-life implications
• Zap the clap with DNA: a novel microbicide for preventing Neisseria gonorrhoeae infection